Why the study?
Does concomitant pulsed-field ablation-based pulmonary vein isolation and left atrial appendage occlusion using the WATCHMAN device achieve high acute procedural success and low periprocedural adverse events in patients with atrial fibrillation?
Observational (n=21)
No
Does concomitant pulsed-field ablation-based pulmonary vein isolation and left atrial appendage occlusion using the WATCHMAN device achieve high acute procedural success and low periprocedural adverse events in patients with atrial fibrillation?
Answers are grounded in this paper and cite their sources.
This single-center experience demonstrates that concomitant pulsed-field ablation pulmonary vein isolation and WATCHMAN left atrial appendage occlusion is feasible with high acute procedural success (100% PVI, 95.2% LAAO) and a low rate of periprocedural adverse events.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Pašara et al. (2026) conducted an observational in Atrial fibrillation with increased thromboembolic and bleeding risk (n=21). Concomitant pulsed-field ablation pulmonary vein isolation and WATCHMAN left atrial appendage occlusion was evaluated on Acute procedural success of WATCHMAN left atrial appendage occlusion (with 100% acute pulmonary vein isolation success).
Synapse has enriched 10 related papers. Consider them for comparative context: